Allied Market Research
Loading...
Cart
0
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

New
New Allied Market Research

Implantable Drug Delivery Devices Market by Material (Silicon and Others), Product Type (Implantable Drug Eluting Stents, Implantable Contraceptive Drug Delivery Devices, Implantable Intraocular Drug Delivery Devices, Implantable Brachytherapy Seeds Devices, and Implantable Drug Delivery Pump Devices) and End User (Hospitals, Ambulatory Surgery Center, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2027

A00350
Pages: 219
Oct 2020 | 5694 Views
 
Author(s) : Trupti Wadekar, Smita Nerkar , Onkar Sumant
Tables: 121
Charts: 48
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Implantable Drug Delivery Devices Market

Request Now !

The global implantable drug delivery devices market was valued at $10,091.9 million in 2019, and is projected to reach $13,211.8 million by 2027 at a CAGR of 8.0% from 2020 to 2027. 

Implantable drug delivery devices are the medical devices that enable site specific drug administration. It also helps in minimizing doses of drug to reduce potential side effects. These devices facilitate sustained release of a therapeutic agent. These implantable devices are gaining edge over conventional oral or parenteral dosage forms, owing to site specific and sustained release therapeutic action of implantable devices, which further minimizes the side-effects associated with the drug. In addition, treatment schedule associated with an implantable device is generally less burdensome than pills or injections.

Implantable-Drug-Delivery-Devices-Market,-2020-2027

Get more information on this report : Request Sample Pages

The COVID-19 outbreak that started from Wuhan city of China has now wide spread globally. Almost every nation is dealing with the outbreak. Most markets are dropping down as COVID-19 outbreak has negatively affected various healthcare related markets. This pandemic is expected to present growth opportunities for the implantable drug delivery devices market in the future. According to the World Heart Federation, 2020, elder people above the age of 60 years and people suffering from underlying medical conditions such as cardiovascular disease, hypertension, diabetes, chronic respiratory disease, and cancer are more prone to coronavirus infection than younger population. Furthermore, according to the World Health Organization (WHO), in April 2, 2020, it was reported that in Europe, 95% of the coronavirus infection was recorded in population older than 60 years, while more than 50% infection was recorded in population of 80 years and above. In addition, to protect the population from coronavirus infection, people should stay away from all containment zones including hospitals. This can be possible by implanting drug delivery devices in patients, which adds an advantage of not personally visiting hospitals for follow-ups or treatment procedures as implantable drug delivery devices offer long term drug delivery. Therefore, the COVID-19 pandemic is expected to drive the implantable drug delivery devices market growth during the forecast period.

Growth of the implantable drug delivery devices market is driven by rise in prevalence of chronic diseases across the globe, increase in demand for minimally invasive drug delivery devices, and unwanted pregnancies over a period. However, possibility of implanted device failures, and stringent government regulations impede the market growth. Conversely, collaboration activities among leading market players are expected to provide lucrative growth opportunities for the implantable drug delivery devices market.

Implantable Drug Delivery Devices Market
By Product Type

Your browser does not support the canvas element.

Implantable drug iluting stents segment holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

The implantable drug delivery devices market is segmented into material, product type, end user, and region. By material, the market is divided into silicon and others. On the basis of product type, implantable drug eluting stents, implantable contraceptive drug delivery devices, Implantable intraocular drug delivery devices, implantable brachytherapy seeds devices, and implantable drug delivery pump devices. By end user, it is classified into hospitals, ambulatory surgery centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Product type segment review

By product type, the implantable drug eluting stents segment accounted for the largest share in 2019. Rise in adoption of implantable products such as drug-eluting stents in coronary artery disease is expected to drive the implantable drug eluting stents market during the forecast period. However, the implantable contraceptive drug delivery devices segment is expected to grow at the highest CAGR from 2020 to 2027.

Implantable Drug Delivery Devices Market
By End User

Your browser does not support the canvas element.

Hospital Segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

North America accounted for the largest share of revenue in 2019, and is anticipated to maintain its dominance from 2020 to 2027, owing to increase in diseases burden across the region, which has also resulted in high clinical urgency to adopt these devices, and numerous developments related to implantable drug delivery devices. However, Asia-Pacific is expected to register highest CAGR during the forecast period, owing to surge in healthcare expenditure as well as awareness levels with respect to benefits of implantable drug delivery devices.

Some of the key players operating in the market include Abbott Laboratories, AbbVie Inc, Bayer AG, Bausch Health Companies Inc., Biotronik, Inc., Boston Scientific Corporation, Medtronic Plc, Merck & co., Inc., Teleflex Incorporated, and Terumo Corporation. Other players in the value chain analysis include, DSM Biomedical and Alimera Sciences, Eyepoint Pharmaceuticals, Delpor Inc., and 3M Company

Implantable Drug Delivery Devices Market
By Region

2027
North America 
Europe
Asia-pacific
Lamea

Asia Pacific region would exhibit the highest CAGR of 9.1% during 2020-2027.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the global implantable drug delivery devices market with current trends and future estimations from 2019 to 2027 to elucidate the imminent investment pockets.
  • Comprehensive analysis of factors that drive and restrict the implantable drug delivery devices market growth is provided.
  • Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
  • A deep dive analysis of various regions provides insights that would allow companies to strategically plan their business moves.
  • Key players are profiled and their strategies are analysed thoroughly to understand the competitive outlook of the implantable drug delivery devices market.

Key Market Segments

By Material

  • Silicon
  • Others

By Product Type

  • Implantable Drug Eluting Stents 
  • Implantable Contraceptive Drug Delivery Devices
  • Implantable Intraocular Drug Delivery Devices
  • Implantable Brachytherapy Seeds Devices
  • Implantable Drug Delivery Pump Devices

By End User

  • Hospitals 
  • Ambulatory Surgery Centers 
  • Others 

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Australia
    • Japan
    • India
    • China
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.List of key players profiled in the report
1.5.Research methodology

1.5.1.Secondary research
1.5.2.Primary research
1.5.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Top player positioning, 2019
3.4.Porter’s five forces analysis
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in prevalence of chronic diseases
3.5.1.2.Rise in demand for minimally invasive drug delivery devices
3.5.1.3.Unwanted pregnancies

3.5.2.Restraints

3.5.2.1.Possibility of implanted device failure
3.5.2.2.Stringent government regulations

3.5.3.Opportunity

3.5.3.1.Collaboration activities among leading players

3.5.4.Impact analysis 

CHAPTER 4:IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL

4.1.Overview

4.1.1.Market size and forecast

4.2.Silicone

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Others

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

CHAPTER 5:IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Implantable Drug Eluting Stents

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Implantable Contraceptive Drug Delivery Devices

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Implantable Intraocular Drug Delivery Devices

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.5.Implantable Brachytherapy Seeds Devices

5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country

5.6.Implantable Drug Delivery Pump Devices

5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country

CHAPTER 6:IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospitals

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Ambulatory Surgery Centers

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

6.4.Others

6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country

CHAPTER 7:IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America implantable drug delivery devices market, by country

7.2.2.1.U.S.

7.2.2.1.1.Market size and forecast, by material
7.2.2.1.2.Market size and forecast, by product type
7.2.2.1.3.Market size and forecast, by end user

7.2.2.2.Canada

7.2.2.2.1.Market size and forecast, by material
7.2.2.2.2.Market size and forecast, by product type
7.2.2.2.3.Market size and forecast, by end user

7.2.2.3.Mexico

7.2.2.3.1.Market size and forecast, by material
7.2.2.3.2.Market size and forecast, by product type
7.2.2.3.3.Market size and forecast, by end user

7.2.3.North America market size and forecast, by material
7.2.4.North America market size and forecast, product type
7.2.5.North America market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe implantable drug delivery devices market, by country

7.3.2.1.Germany

7.3.2.1.1.Market size and forecast, by material
7.3.2.1.2.Market size and forecast, by product type
7.3.2.1.3.Market size and forecast, by end user

7.3.2.2.UK

7.3.2.2.1.Market size and forecast, by material
7.3.2.2.2.Market size and forecast, by product type
7.3.2.2.3.Market size and forecast, by end user

7.3.2.3.France

7.3.2.3.1.Market size and forecast, by material
7.3.2.3.2.Market size and forecast, by product type
7.3.2.3.3.Market size and forecast, by end user

7.3.2.4.Italy

7.3.2.4.1.Market size and forecast, by material
7.3.2.4.2.Market size and forecast, by product type
7.3.2.4.3.Market size and forecast, by end user

7.3.2.5.Spain

7.3.2.5.1.Market size and forecast, by material
7.3.2.5.2.Market size and forecast, by product type
7.3.2.5.3.Market size and forecast, by end user

7.3.2.6.Rest of Europe

7.3.2.6.1.Market size and forecast, by material
7.3.2.6.2.Market size and forecast, by product type
7.3.2.6.3.Market size and forecast, by end user

7.3.3.Europe market size and forecast, by material
7.3.4.Europe market size and forecast, product type
7.3.5.Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific implantable drug delivery devices market, by country

7.4.2.1.China

7.4.2.1.1.Market size and forecast, by material
7.4.2.1.2.Market size and forecast, by product type
7.4.2.1.3.Market size and forecast, by end user

7.4.2.2.Japan

7.4.2.2.1.Market size and forecast, by material
7.4.2.2.2.Market size and forecast, by product type
7.4.2.2.3.Market size and forecast, by end user

7.4.2.3.Australia

7.4.2.3.1.Market size and forecast, by material
7.4.2.3.2.Market size and forecast, by product type
7.4.2.3.3.Market size and forecast, by end user

7.4.2.4.India

7.4.2.4.1.Market size and forecast, by material
7.4.2.4.2.Market size and forecast, by product type
7.4.2.4.3.Market size and forecast, by end user

7.4.2.5.South Korea

7.4.2.5.1.Market size and forecast, by material
7.4.2.5.2.Market size and forecast, by product type
7.4.2.5.3.Market size and forecast, by end user

7.4.2.6.Rest of Asia-Pacific

7.4.2.6.1.Market size and forecast, by material
7.4.2.6.2.Market size and forecast, by product type
7.4.2.6.3.Market size and forecast, by end user

7.4.3.Asia-Pacific market size and forecast, by material
7.4.4.Asia-Pacific market size and forecast, product type
7.4.5.Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA implantable drug delivery devices market, by country

7.5.2.1.Brazil

7.5.2.1.1.Market size and forecast, by material
7.5.2.1.2.Market size and forecast, by product type
7.5.2.1.3.Market size and forecast, by end user

7.5.2.2.Saudi Arabia

7.5.2.2.1.Market size and forecast, by material
7.5.2.2.2.Market size and forecast, by product type
7.5.2.2.3.Market size and forecast, by end user

7.5.2.3.South Africa

7.5.2.3.1.Market size and forecast, by material
7.5.2.3.2.Market size and forecast, by product type
7.5.2.3.3.Market size and forecast, by end user

7.5.2.4.Rest of LAMEA

7.5.2.4.1.Market size and forecast, by material
7.5.2.4.2.Market size and forecast, by product type
7.5.2.4.3.Market size and forecast, by end user

7.5.3.LAMEA market size and forecast, by material
7.5.4.LAMEA market size and forecast, product type
7.5.5.LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.ABBOTT LABORATORIES

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments

8.2.ABBVIE INC.

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments

8.3.Bayer AG.

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance

8.4.BAUSCH HEALTH COMPANIES INC.

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance

8.5.BIOTRONIK, INC.

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Key strategic moves and developments

8.6.BOSTON SCIENTIFIC CORPORATION

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments

8.7.MEDTRONIC PLC.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments

8.8.MERCK & CO., INC.

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance

8.9.TELEFLEX INCORPORATED

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance

8.10.TERUMO CORPORATION

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.1.Key strategic moves and developments

LIST OF TABLES

TABLE 01.IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 02.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR SILICON, BY REGION, 2019–2027 ($MILLION)
TABLE 03.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 04.IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 05.IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 (THOUSAND UNITS)
TABLE 06.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR IMPLANTABLE DRUG ELUTING STENTS, BY REGION, 2019–2027 ($MILLION)
TABLE 07.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR IMPLANTABLE CONTRACEPTIVE DRUG DELIVERY DEVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 08.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR IMPLANTABLE INTRAOCULAR DRUG DELIVERY DEVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 09.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR IMPLANTABLE BRACHYTHERAPY SEEDS DEVICES, BY REGION,  2019–2027 ($MILLION)
TABLE 10.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR IMPLANTABLE DRUG DELIVERY PUMP DEVICES, BY REGION,  2019–2027 ($MILLION)
TABLE 11.IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 12.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR HOSPITALS, BY REGION, 2019–2027 ($MILLION)
TABLE 13.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS , BY REGION, 2019–2027 ($MILLION)
TABLE 14.IMPLANTABLE DRUG DELIVERY DEVICES MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 15.IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 16.NORTH AMERICA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 17.U.S. IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 18.U.S. IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 19.U.S. IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019–2027 ($MILLION)
TABLE 20.CANADA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 21.CANADA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 22.CANADA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 23.MEXICO IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 24.MEXICO IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 25.MEXICO IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019–2027 ($MILLION)
TABLE 26.NORTH AMERICA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 27.NORTH AMERICA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 28.NORTH AMERICA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019–2027 ($MILLION)
TABLE 29.EUROPE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 30.GERMANY IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 31.GERMANY IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 32.GERMANY IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019–2027 ($MILLION)
TABLE 33.UK IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 34.UK IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 35.UK IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019–2027 ($MILLION)
TABLE 36.FRANCE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 37.FRANCE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 38.FRANCE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019–2027 ($MILLION)
TABLE 39.ITALY IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 40.ITALY IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 41.ITALY IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 42.SPAIN IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 43.SPAIN IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 44.SPAIN IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 45.REST OF EUROPE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 46.REST OF EUROPE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 47.REST OF EUROPE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 48.EUROPE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 49.EUROPE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 50.EUROPE IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019–2027 ($MILLION)
TABLE 51.ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 52.CHINA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 53.CHINA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 54.CHINA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019–2027 ($MILLION)
TABLE 55.JAPAN IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 56.JAPAN IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 57.JAPAN IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019–2027 ($MILLION)
TABLE 58.AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 59.AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 60.AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019–2027 ($MILLION)
TABLE 61.INDIA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 62.INDIA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 63.INDIA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 64.SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 65.SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 66.SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 67.REST OF ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 68.REST OF ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 69.REST OF ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 70.ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 71.ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 72.ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 73.LAMEA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 74.BRAZIL IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 75.BRAZIL IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 76.BRAZIL IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019–2027 ($MILLION)
TABLE 77.SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 78.SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 79.SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019–2027 ($MILLION)
TABLE 80.SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 81.SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 82.SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BYEND USER, 2019–2027 ($MILLION)
TABLE 83.REST OF LAMEA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 84.REST OF LAMEA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 85.REST OF LAMEA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 86.LAMEA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2019–2027 ($MILLION)
TABLE 87.LAMEA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 88.LAMEA IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 89.ABBOTT: COMPANY SNAPSHOT
TABLE 90.ABBOTT: OERATING SEGMENT
TABLE 91.ABBOTT: PRODUCT PORTFOLIO
TABLE 92.ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 93.ABBVIE: COMPANY SNAPSHOT
TABLE 94.ABBVIE: OERATING SEGMENT
TABLE 95.ABBVIE: PRODUCT PORTFOLIO
TABLE 96.ABBVIE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 97.BAYER: COMPANY SNAPSHOT
TABLE 98.BAYER: OPERATING SEGMENTS
TABLE 99.BAYER: PRODUCT PORTFOLIO
TABLE 100.BAUSCH: COMPANY SNAPSHOT
TABLE 101.BAUSCH: OPERATING SEGMENTS
TABLE 102.BAUSCH: PRODUCT PORTFOLIO
TABLE 103.BIOTRONIK: COMPANY SNAPSHOT
TABLE 104.BIOTRONIK: OPERATING SEGMENTS
TABLE 105.BIOTRONIK: PRODUCT PORTFOLIO
TABLE 106.BIOTRONIK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107.BOSTON: COMPANY SNAPSHOT
TABLE 108.BOSTON: OPERATING SEGMENTS
TABLE 109.BOSTON: PRODUCT PORTFOLIO
TABLE 110.MEDTRONIC: COMPANY SNAPSHOT
TABLE 111.MEDTRONIC: OPERATING SEGMENTS
TABLE 112.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 113.MERCK: COMPANY SNAPSHOT
TABLE 114.MERCK: OPERATING SEGMENTS
TABLE 115.MERCK PRODUCT PORTFOLIO
TABLE 116.TELEFLEX: COMPANY SNAPSHOT
TABLE 117.TELEFLEX: OERATING SEGMENT
TABLE 118.TELEFLEX: PRODUCT PORTFOLIO
TABLE 119.TERUMO: COMPANY SNAPSHOT
TABLE 120.TERUMO: OERATING SEGMENT
TABLE 121.TERUMO: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.IMPLANTABLE DRUG DELIVERY DEVICES MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017–2020 *
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2020 (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020
FIGURE 06.TOP PLAYER POSITIONING, 2019
FIGURE 07.MODERATE BARGANING POWER OF SUPPLIERS
FIGURE 08.MODERATE BARGAINING POWER OF BUYERS
FIGURE 09.MODERATE THREAT OF NEW ENTRANT
FIGURE 10.MODERATE THREAT OF SUBSTITUTION
FIGURE 11.MODERATE COMPETITIVE RIVALRY
FIGURE 12.IMPACT ANALYSES
FIGURE 13.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY SILICON MARKET, 2019–2027 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY OTHER, BY REGION,  2019–2027 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY IMPLANTABLE DRUG ELUTING STENTS MARKET, 2019–2027 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY IMPLANTABLE CONTRACEPTIVE DRUG DELIVERY DEVICES, 2019–2027 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY IMPLANTABLE INTRAOCULAR DRUG DELIVERY DEVICES, 2019–2027 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY IMPLANTABLE BRACHYTHERAPY SEEDS DEVICES, 2019–2027 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY DRUG DELIVERY PUMP DEVICES, 2019–2027 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY HOSPITALS MARKET,  2019–2027 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET , BY AMBULATORY SURGERY CENTERS , 2019–2027 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF IMPLANTABLE DRUG DELIVERY DEVICES MARKET, BY OTHER,  2019–2027 ($MILLION)
FIGURE 23.ABBOTT: NET SALES, 2017–2019 ($MILLION)
FIGURE 24.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 25.ABBOTT: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 26.ABBVIE: NET SALES, 2017–2019 ($MILLION)
FIGURE 27.ABBVIE: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 28.BAYER: NET SALES, 2017–2019 ($MILLION)
FIGURE 29.BAYER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 30.BAYER: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 31.BAUSCH: NET SALES, 2017–2019 ($MILLION)
FIGURE 32.BAUSCH: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 33.BAUSCH: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 34.BOSTON: NET SALES, 2017–2019 ($MILLION)
FIGURE 35.BOSTON: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 36.BOSTON: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 37.MEDTRONIC: NET SALES, 2017–2019 ($MILLION)
FIGURE 38.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 39.MEDTRONIC: REVENUE SHARE, BY GEOGRAPHY, 2019 (%)
FIGURE 40.MERCK: NET SALES, 2017–2019 ($MILLION)
FIGURE 41.MERCK: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 42.MERCK: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 43.TELEFLEX: NET SALES, 2017–2019 ($MILLION)
FIGURE 44.TELEFLEX: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 45.TELEFLEX: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 46.TERUMO: NET SALES, 2017–2019 ($MILLION)
FIGURE 47.TERUMO: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 48.TERUMO: REVENUE SHARE, BY REGION, 2019 (%)

 
 

This section provides opinions of CXOs of key companies operating in the implantable drug delivery devices industry. According to them, the adoption of implantable drug delivery devices is expected to increase owing to rise in chronic diseases, medical procedures, high demand for less painful and minimally-invasive device types, and rise in number of geriatric populations across the globe. Moreover, factors such as unwanted pregnancies over a period and surge in affordability in developing economies are projected to supplement the market growth. 

However, stringent government regulations for approval of drug delivery devices and ignorance of new and effective drug delivery devices are expected to hinder the market growth. In addition, use of implantable drug delivery devices is highest in North America, owing to rise in adoption of advanced implantable drug delivery products and high expenditure by governments on healthcare, followed by Europe and Asia-Pacific. In addition, implantable drug delivery device providers and distributors focus to expand their presence in the emerging economies, which is anticipated to drive the market growth.
 

 
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of Implantable Drug Delivery Devices Market is $10,091.9 million in 2019.

A. The forcast period for Implantable Drug Delivery Devices Market is 2020 to 2027

A. The market value of Implantable Drug Delivery Devices Market in 2020 is $7,690.21million.

A. The base year is 2019 in Implantable Drug Delivery Devices Market

A. Top companies such as, Abbott Laboratories, AbbVie Inc, Bayer AG, Bausch Health Companies Inc., Biotronik, Inc., Boston Scientific Corporation, Medtronic Plc, Merck & co., Inc., Teleflex Incorporated, and Terumo Corporation.

A. Implantable drug eluting stents segment segment is the most influencing segment. Rise in adoption of implantable products such as drug-eluting stents in coronary artery disease is expected to drive the implantable drug eluting stents market during the forecast period.

A. The major factor that fuels the growth of the Implantable Drug Delivery Devices market includes rise in prevalence of chronic diseases across the globe, increase in demand for minimally invasive drug delivery devices, and unwanted pregnancies over a period.

A. No, there is no value chain analysis provided in the Implantable Drug Delivery Devices Market report

A. Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body some time based on nanoparticles as needed to safely achieve its desired therapeutic effect.

A. Yes, Implantable Drug Delivery Devices companies are profiled in the report.

Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Implantable Drug Delivery Devices Market

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers